IDT Australia Ltd (IDT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:IDT Australia Ltd (IDT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12397
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes in the post-discovery pharmaceutical life cycle. It manages Cytotoxic API’s, high potency API’s, anti-cancer drugs, antibiotics, anti-psychotics, beta lactams and controlled drugs. IDT provides a wide range of services, which can be customized to meet the specific requirements of its customer. The company also provides specialist clinical trial labeling, packaging and dispensing services. IDT is headquartered in Boronia, Victoria, Australia.

IDT Australia Ltd (IDT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IDT Australia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
IDT Australia Acquires Generic Drugs from Global Generics Company for USD14.8 Million 10
IDT Australia to Acquire Synthetic Conjugated Estrogens from Perrigo 11
Partnerships 12
Mayne Pharma Enters into Distribution Agreement with IDT Australia 12
ANI Pharma Enters into Agreement with IDT Australia 13
Equity Offering 14
WellSpring Pharma Services Invests USD3 Million in IDT Australia 14
IDT Australia Completes Private Placement Of Shares For US$2.8 Million 15
IDT Australia Completes Private Placement Of Shares For US$0.8 Million 16
IDT Australia Completes Rights Offering Of Shares For US$1.8 Million 17
Asset Transactions 18
ANI Pharma Acquires Generic ANDA Product Portfolio from IDT Australia for USD2.7 Million 18
I’rom Group Completes Acquisition of CMAX Clinical Trial Business from IDT Australia 19
Acquisition 21
I’rom Group to Acquire 61% Stake in CMAX from IDT Australia for USD7.6 Million 21
I’rom Completes Acquisition Of 18.8% Stake In IDT Australia For US$2 Million 22
IDT Australia Ltd – Key Competitors 23
IDT Australia Ltd – Key Employees 24
IDT Australia Ltd – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Financial Announcements 26
Aug 23, 2018: IDT Australia: Preliminary final report for the year ended 30 June 2018 26
Corporate Communications 27
Jul 02, 2018: IDT Australia Appoints Chief Executive Officer 27
Feb 16, 2018: IDT Australia Names Dr David Sparling As Interim Chief Executive Officer 28
Jun 13, 2017: IDT Australia: Dr Graeme Blackman AO retires 29
Legal and Regulatory 30
Jul 25, 2018: IDT Australia: FDA Meeting Update 30
Other Significant Developments 31
Jun 08, 2018: IDT Australia: Update on Response to Fda Warning Letter 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
IDT Australia Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IDT Australia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IDT Australia Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
IDT Australia Acquires Generic Drugs from Global Generics Company for USD14.8 Million 10
IDT Australia to Acquire Synthetic Conjugated Estrogens from Perrigo 11
Mayne Pharma Enters into Distribution Agreement with IDT Australia 12
ANI Pharma Enters into Agreement with IDT Australia 13
WellSpring Pharma Services Invests USD3 Million in IDT Australia 14
IDT Australia Completes Private Placement Of Shares For US$2.8 Million 15
IDT Australia Completes Private Placement Of Shares For US$0.8 Million 16
IDT Australia Completes Rights Offering Of Shares For US$1.8 Million 17
ANI Pharma Acquires Generic ANDA Product Portfolio from IDT Australia for USD2.7 Million 18
I'rom Group Completes Acquisition of CMAX Clinical Trial Business from IDT Australia 19
I’rom Group to Acquire 61% Stake in CMAX from IDT Australia for USD7.6 Million 21
I'rom Completes Acquisition Of 18.8% Stake In IDT Australia For US$2 Million 22
IDT Australia Ltd, Key Competitors 23
IDT Australia Ltd, Key Employees 24

List of Figures
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[IDT Australia Ltd (IDT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Horizon Healthcare Services Inc:企業の戦略的SWOT分析
    Horizon Healthcare Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Epax Norway AS:企業の戦略・SWOT・財務情報
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Exelon Generation Company LLC:発電所・企業SWOT分析
    Exelon Generation Company LLC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • inVentiv Health Inc-製薬・医療分野:企業M&A・提携分析
    Summary inVentiv Health Inc (inVentiv) is a Clinical Research Organization (CRO) and Contract Commercial Organization (CCO). The company offers a broad range of clinical development and commercialization services develop and marketing their products and services. Few of its service offerings include …
  • Quadra – Power Generation (TGKD):企業の財務・戦略的SWOT分析
    Quadra - Power Generation (TGKD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Phenex Pharmaceuticals AG-製薬・医療分野:企業M&A・提携分析
    Summary Phenex Pharmaceuticals AG (Phenex) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services which include contract screening services, NR selectivity screening and SNuRM profiling to pharmaceutical, biotechno …
  • Qsc AG (QSC):企業の財務・戦略的SWOT分析
    Summary Qsc AG (Qsc) is a telecommunication company that provides integrated telecommunication and managed services. The company offers services such as cloud and IT outsourcing, Internet of Things services, sap services and consulting, broadband and network services, and colocation services. Its cl …
  • Heathrow Airport Holdings Limited
    Heathrow Airport Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Heathrow Airport Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • iiNet Limited:企業の戦略・SWOT・財務情報
    iiNet Limited - Strategy, SWOT and Corporate Finance Report Summary iiNet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Atlas Consolidated Mining and Development Corporation:企業の戦略・SWOT・財務情報
    Atlas Consolidated Mining and Development Corporation - Strategy, SWOT and Corporate Finance Report Summary Atlas Consolidated Mining and Development Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Cedar Fair, L.P.:企業の戦略・SWOT・財務情報
    Cedar Fair, L.P. - Strategy, SWOT and Corporate Finance Report Summary Cedar Fair, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Midea Group Co Ltd:企業の戦略・SWOT・財務情報
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Inovio Pharmaceuticals Inc (INO):医療機器:M&Aディール及び事業提携情報
    Summary Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology …
  • Mitsubishi Research Institute Inc (3636):企業の財務・戦略的SWOT分析
    Mitsubishi Research Institute Inc (3636) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Carl Zeiss Meditec AG (AFX):製品パイプライン分析
    Summary Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, an integrated medical technology company which operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. It provides comprehensive packages of solutions for the diagnosis and treatment of ey …
  • Seylan Bank Plc:企業の戦略・SWOT・財務情報
    Seylan Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Seylan Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd:企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • Futuren (FTRN):電力:M&Aディール及び事業提携情報
    Summary Futuren, previously Theolia SA, is a wind energy producer that prospects, develops, constructs, installs and operates wind power projects. It specializes in designing and building onshore wind plants. Futuren conducts these operations for its own account as well as for third parties. The com …
  • Abivax SA (ABVX):企業の財務・戦略的SWOT分析
    Summary Abivax SA (Abivax) is a biotechnology company that develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to induce f …
  • ResApp Health Ltd (RAP):企業の製品パイプライン分析
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆